Biotech is a growth theme regardless of coronavirus concerns: Investor

Michael Cuggino of Permanent Portfolio of Family Funds says the surge in pharma and biotech stocks is not driven by the search for a coronavirus vaccine alone. He adds that the U.S. economy can continue to grow within the time it would take to find a vaccine.